Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Nov 12;383(20):1986-1988.
doi: 10.1056/NEJMe2025111. Epub 2020 Jul 14.

The Covid-19 Vaccine-Development Multiverse

Affiliations
Editorial

The Covid-19 Vaccine-Development Multiverse

Penny M Heaton. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Traditional Vaccine Development Pathway.

Comment in

  • The Covid-19 Vaccine-Development Multiverse.
    Kojima N, Turner I, Klausner JD. Kojima N, et al. N Engl J Med. 2021 Feb 18;384(7):681-682. doi: 10.1056/NEJMc2034838. Epub 2021 Jan 27. N Engl J Med. 2021. PMID: 33503338 No abstract available.

Comment on

  • An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
    Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH; mRNA-1273 Study Group. Jackson LA, et al. N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14. N Engl J Med. 2020. PMID: 32663912 Free PMC article. Clinical Trial.

References

    1. Coronavirus disease (COVID-19) pandemic. Geneva: World Health Organization, 2020. (https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=EA...).
    1. Williamson EJ, Walker AJ, Bhaskaran K, et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients. Nature. 2020. July 8 (Epub ahead of print). - PMC - PubMed
    1. Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS-CoV-2 — preliminary report. N Engl J Med. DOI: 10.1056/NEJMoa2022483. - DOI - PMC - PubMed
    1. Martin JE, Louder MK, Holman LA, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine 2008;26:6338-6343. - PMC - PubMed
    1. Folegatti PM, Bittaye M, Flaxman A, et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis 2020;20:816-826. - PMC - PubMed